Myriad Genetics (MYGN) Reports In-Line Q2 EPS, Revenues Beat

Go back to Myriad Genetics (MYGN) Reports In-Line Q2 EPS, Revenues Beat
Myriad Genetics, Inc. (NASDAQ: MYGN) Delayed: 4.54 --0 (-0%)
Previous Close $4.54    52 Week High $45.34 
Open $4.54    52 Week Low $15.92 
Day High $4.54    P/E 1.95 
Day Low $4.54    EPS $2.33 
Volume 216